Patrys Limited (ASX:PAB)

ALERT: Price-sensitive ASX Announcement for PAB

Current share price for PAB : $0.041 0.004 (10.81%)⁺

Announcement

Appointment of Chief Executive Officer

Release

12 Feb 2026 8:13AM

Price at Release

$0.037

Full Release

Summary

Patrys Limited (ASX: PAB) announced the appointment of Dr. Samantha South as the new Chief Executive Officer, effective 16 February 2026. Dr. South brings extensive experience in biotechnology, having previously held leadership roles at Argenica Therapeutics and other major Australian research institutions. Her experience spans preclinical development, regulatory strategies, and commercialisation. Patrys anticipates that Dr. South's expertise will drive their transition into a dual-platform clinical-stage company, following a recent expansion of their pipeline. The board and Dr. South are committed to enhancing shareholder value through strategic development and efficient execution.

Key Points

Appointment of Dr. Samantha South as CEO of Patrys Limited, effective 16 February 2026.
Dr. South has a strong background in biotechnology and regulatory strategies.
Previously held leadership roles at Argenica Therapeutics and major Australian research institutions.
The appointment aligns with Patrys' evolution into a clinical-stage company.
Dr. South is committed to strategic development and shareholder value enhancement.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.